RecruitingPhase 3ACTRN12605000017628

Effect of Vitamin D Supplementation on Blood Pressure and Insulin Sensitivity

A randomised phase III study to evaluate the effects of Vitamin D supplementation on patients with low vitamin D levels to reduce blood pressure levels and improve insulin sensitivity


Sponsor

University of Auckland

Enrollment

120 participants

Start Date

Jul 7, 2005

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 40 Yearss

Plain Language Summary

Simplified for easier understanding

This study looks at whether taking vitamin D supplements can help lower blood pressure and improve the body's ability to use insulin (which regulates blood sugar). It focuses on people who have low vitamin D levels, particularly in Tongan, Maori, and European communities. You may be eligible if: - You are 40 years or older (if Tongan or Maori) or 65 years or older (if European) - Your vitamin D level (25OHD) is below 50 nmol/L (a blood test will show this) You may NOT be eligible if: - You are currently being treated for diabetes or high blood pressure - You are already taking vitamin D supplements or cod liver oil - Your blood calcium level is too high - You spend a lot of time outdoors in the middle of the day - You have recently had a holiday in a very sunny location or are planning one during the study Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

A randomised double-blind clinical trial of 100 ug daily doses of vitamin D3 versus placebo tablets.

A randomised double-blind clinical trial of 100 ug daily doses of vitamin D3 versus placebo tablets.


Locations(1)

New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000017628


Related Trials